ESR1 and breast carcinoma: Furthermore, increasing the concentration of SM6Met in combination with 4-OH-Tam to a ratio of 20:1 resulted in an overall inhibition of ER+ breast cancer cell migration not seen with either 4-OH-Tam or SM6Met alone.